Prostate Cancer Metastatic Disease

Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Lab Research Using Mini-tumors to Study Prostate Cancer Treatments

Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Using FAPI PET/MRI to Evaluate Prostate Cancer

PSMA PET for Surveillance After Focal Therapy

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer

Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer

Role of Race in Nutritional Approach in Men on ADT

HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)

A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer

Osteosclerotic Changes on CT Predict Survival in Prostate Cancer

Study of HRS-2189 Combined HRS-5041 in Prostate Cancer

Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer